...
首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage
【24h】

Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage

机译:在缺血期间将亚硝酸盐还原为一氧化氮可防止心肌缺血-再灌注损伤

获取原文
获取原文并翻译 | 示例
           

摘要

Nitric oxide (NO.) is thought to protect against the damaging effects of myocardial ischemia-reperfusion injury, whereas xanthine oxidoreductase (XOR) normally causes damage through the generation of reactive oxygen species. In the heart, inorganic nitrite (NO2-) has the potential to act as an endogenous store of NO. liberated specifically during ischemia. Using a detection method that we developed, we report that under ischemic conditions both rat and human homogenized myocardium and the isolated perfused rat heart (Langendorff preparation) generate NO. from NO2- in a reaction that depends on XOR activity. Functional studies of rat hearts in the Langendorff apparatus showed that nitrite (10 and 100 muM) reduced infarct size from 47.3 +/- 2.8% (mean percent of control +/- SEM) to 17.9 +/- 4.2% and 17.4 +/- 1.0%, respectively (P < 0.001), and was associated with comparable improvements in recovery of left ventricular function. This protective effect was completely blocked by the NO. scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazole-1-oxyl 3-oxide (carboxy-PTIO). In summary, the generation of NO. from NO2-, by XOR, protects the myocardium from ischemia-reperfusion injury. Hence, if XOR is presented with NO2- as an alternative substrate, the resultant effects of its activity may be protective, by means of its production of NO., rather than damaging.
机译:一氧化氮(NO。)被认为可以防止心肌缺血-再灌注损伤的破坏作用,而黄嘌呤氧化还原酶(XOR)通常通过产生活性氧而引起损害。在心脏中,无机亚硝酸盐(NO2-)可能充当NO的内源性存储。在缺血过程中特别释放。使用我们开发的检测方法,我们报告说,在缺血条件下,大鼠和人的均质心肌以及分离的灌注大鼠心脏(Langendorff制剂)均会产生NO。在取决于XOR活性的反应中由NO2-生成。在Langendorff装置中对大鼠心脏进行的功能研究表明,亚硝酸盐(10和100μM)将梗塞面积从47.3 +/- 2.8%(相对于对照组+/- SEM的平均百分比)降低到17.9 +/- 4.2%和17.4 +/-分别为1.0%(P <0.001),并且与左心室功能恢复的可比改善有关。 NO完全阻止了这种保护作用。清除剂2-(4-羧基苯基)-4,4,5,5-四甲基咪唑-1-氧基3-氧化物(羧基-PTIO)。综上所述,NO的产生。 XOR的NO2-可以保护心肌免受缺血再灌注损伤。因此,如果将XOR与NO2-作为替代底物一起使用,则其活性所产生的最终效果可能会通过生成NO。而起到保护作用,而不是造成损害。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号